top of page
Search

Clindamycin 2-Phosphate Sulfoxide: Chemical Structure, Characterization, and Analytical Significance

Ayeisha Sanghvi
Oct 21
9 min read

Clindamycin 2-Phosphate Sulfoxide is a structurally related compound associated with the pharmaceutical chemistry of Clindamycin Phosphate. Its chemical structure contains a sulfoxide functional group within the sulfur-containing portion of the clindamycin molecule, together with a phosphate ester group. These structural features make it an important compound to consider when investigating related substances, oxidative transformation products, and the chemical composition of Clindamycin Phosphate materials.


Clindamycin is a lincosamide antibiotic used in pharmaceutical formulations. Clindamycin Phosphate is a phosphate ester derivative developed for pharmaceutical applications, particularly in topical and parenteral formulations. During pharmaceutical development and manufacturing, the chemical stability of an active pharmaceutical ingredient (API) is an important consideration. Changes in environmental conditions, processing parameters, and storage conditions may influence the formation or presence of related substances.


For analytical researchers, identifying structurally related compounds is essential for understanding the impurity profile of an API. Clindamycin 2-Phosphate Sulfoxide is relevant in this context because its structure differs from the parent phosphate compound through oxidation at the sulfur centre.


Pharmaceutical impurity reference standards help researchers investigate such compounds using appropriate analytical techniques. Chemicea offers Clindamycin 2-Phosphate Sulfoxide as part of its Clindamycin-related impurity portfolio, supporting research and analytical requirements involving pharmaceutical reference materials.



Chemical Structure and Molecular Characteristics


Understanding the molecular structure of Clindamycin 2-Phosphate Sulfoxide provides a foundation for its identification and analytical characterization.


The compound contains several important structural elements, including:


  • A substituted sugar-derived ring system.

  • A chlorine-containing side chain.

  • A methylsulfinyl functional group.

  • A pyrrolidine-containing amide portion.

  • A phosphate ester group.


The sulfoxide functionality is particularly significant. It contains a sulfur atom bonded to an oxygen atom, resulting in a different oxidation state from the corresponding thioether group found in the parent clindamycin structure.


The phosphate group is another important structural feature. It contributes to the molecular composition and distinguishes this compound from Clindamycin Sulfoxide, which does not contain the phosphate ester group.


Chemical and Molecular Information


The following molecular information is listed for Clindamycin 2-Phosphate Sulfoxide in PubChem and Chemicea's product catalogue.


Parameter

Details

Compound name

Clindamycin 2-Phosphate Sulfoxide

CAS Number

1228573-90-7

Molecular formula

C18H34ClN2O9PS

Molecular weight

520.96 g/mol

PubChem CID

129011911

Chemicea CAT. No.

CP-C26015


The molecular formula indicates the presence of carbon, hydrogen, chlorine, nitrogen, oxygen, phosphorus, and sulfur atoms. The combination of phosphate and sulfoxide functionalities provides useful structural information when selecting analytical approaches.


The compound should also be distinguished from other Clindamycin-related oxidation products. In particular, Clindamycin 2-Phosphate Sulfone contains an additional oxygen atom compared with the sulfoxide compound. This difference is reflected in its molecular formula and molecular weight.


Understanding the Sulfoxide Functional Group


Sulfoxides are organosulfur compounds characterized by a sulfur–oxygen bond. They are commonly encountered in pharmaceutical chemistry as oxidation products of sulfur-containing molecules.


In Clindamycin 2-Phosphate Sulfoxide, the sulfur-containing portion of the clindamycin structure is present in its oxidized sulfoxide form.


The oxidation state of sulfur is an important consideration when studying related substances. A thioether can undergo oxidation to form a sulfoxide, and further oxidation can produce a sulfone. These transformations involve changes in molecular composition and can influence chromatographic retention, mass spectrometric behaviour, and other analytical characteristics.


However, the actual formation and distribution of a particular impurity depend on the compound, reaction environment, formulation, and processing conditions. The presence of a sulfoxide structure alone does not establish the precise conditions under which the compound formed.


For pharmaceutical researchers, distinguishing between sulfoxide and sulfone compounds is important because they represent different chemical entities and should not be treated as interchangeable reference materials.


Formation and Chemical Significance of Clindamycin 2-Phosphate Sulfoxide


Oxidative transformations are an important area of investigation when evaluating sulfur-containing pharmaceutical compounds.


The thioether functionality in a parent molecule may undergo oxidation under suitable chemical conditions. Depending on the reaction environment, the resulting products may include sulfoxide and sulfone derivatives.


For Clindamycin Phosphate, the identification of related sulfur-containing compounds can contribute to a broader understanding of its chemical stability and impurity profile.


Potential factors considered during oxidative stability investigations include:


  • Exposure to oxygen and other oxidizing environments.

  • Temperature variations during processing or storage.

  • Compatibility with formulation ingredients.

  • Manufacturing and purification conditions.

  • Exposure to light and environmental influences.


These factors should be evaluated experimentally rather than assumed to cause the formation of a particular impurity.


Clindamycin 2-Phosphate Sulfoxide is therefore relevant to analytical investigations where researchers need to distinguish the parent pharmaceutical compound from structurally related oxidation products.



Analytical Characterization Techniques


Reliable identification of Clindamycin 2-Phosphate Sulfoxide requires suitable analytical techniques capable of evaluating its molecular composition and structural characteristics.


Different analytical methods provide complementary information. Chromatographic techniques help separate related substances, while spectroscopic and mass spectrometric methods provide structural evidence.


1. High-Performance Liquid Chromatography (HPLC)

High-Performance Liquid Chromatography is widely used for separating pharmaceutical compounds and related impurities.


For Clindamycin 2-Phosphate Sulfoxide, an appropriately developed chromatographic method may help evaluate its separation from Clindamycin Phosphate and other related compounds.


Important method-development considerations include:


  • Selection of a suitable stationary phase.

  • Mobile-phase composition and pH.

  • Gradient or isocratic elution conditions.

  • Column temperature.

  • Detection wavelength and detector suitability.

  • Resolution between relevant related substances.


The method should be evaluated for specificity and suitability for its intended analytical purpose. Retention time alone should not be considered sufficient evidence of compound identity.


2. Liquid Chromatography–Mass Spectrometry (LC-MS)


LC-MS combines chromatographic separation with mass-based detection.


It is particularly useful when investigating pharmaceutical impurities with similar molecular structures.


The molecular formula of Clindamycin 2-Phosphate Sulfoxide corresponds to an average molecular weight of approximately 521 g/mol. Its mass spectrometric response can be investigated using suitable ionization conditions and interpretation of the observed ions.


LC-MS can support:


  • Molecular mass assessment.

  • Detection of related substances.

  • Differentiation of compounds with different molecular compositions.

  • Investigation of degradation-related products.

  • Supportive structural identification.


Published research on Clindamycin Phosphate and its related impurities demonstrates the value of liquid chromatography coupled with electrospray ionization mass spectrometry for impurity separation and characterization.


3. High-Resolution Mass Spectrometry (HRMS)


High-Resolution Mass Spectrometry provides accurate mass measurements that can support molecular formula assessment.


For structurally related pharmaceutical compounds, accurate mass data can help distinguish compounds with different elemental compositions.


However, compounds with identical molecular formulas may produce similar exact-mass measurements. Consequently, HRMS should be combined with other analytical evidence when differentiating sulfoxide isomers or other closely related substances.


4. Nuclear Magnetic Resonance (NMR) Spectroscopy


NMR spectroscopy provides information about the chemical environment of atoms within a molecule.


For Clindamycin 2-Phosphate Sulfoxide, proton and carbon NMR studies may help evaluate structural features associated with the sugar-derived ring, side chain, and other molecular regions.


NMR can be useful for:


  • Confirming structural features.

  • Evaluating chemical environments.

  • Supporting differentiation of structural isomers.

  • Investigating molecular integrity.

  • Providing complementary evidence alongside LC-MS and HPLC.


The combination of NMR and mass spectrometry is particularly useful when comprehensive structural characterization is required.


5. Fourier Transform Infrared Spectroscopy (FTIR)


FTIR spectroscopy provides information about functional groups through their characteristic infrared absorption patterns.


For this compound, FTIR analysis may support the investigation of phosphate, hydroxyl, amide, and sulfur–oxygen-related structural features.


FTIR is generally most useful as a complementary identification technique rather than as a standalone method for distinguishing closely related impurities.


Importance in Pharmaceutical Impurity Profiling


Pharmaceutical impurity profiling is an essential part of drug development, manufacturing, and quality control. It involves identifying, separating, and evaluating substances that may be present alongside an active pharmaceutical ingredient.


For Clindamycin Phosphate, related substances may originate from different chemical pathways, including synthesis-related variations, degradation, or oxidative transformations.


Clindamycin 2-Phosphate Sulfoxide is relevant to this work because it represents a chemically distinct sulfur-oxidized derivative of Clindamycin Phosphate.


Its analytical evaluation can help researchers:

  • Investigate the presence of structurally related compounds.

  • Understand potential oxidative transformation pathways.

  • Develop chromatographic methods for related-substance separation.

  • Improve impurity identification and characterization.

  • Support pharmaceutical quality-control investigations.

  • Evaluate the specificity of analytical procedures.


Published research has demonstrated the importance of chromatographic separation and mass spectrometric characterization in studying Clindamycin Phosphate-related impurities. Researchers have used HPLC, LC-MS, high-resolution mass spectrometry, and NMR to investigate and identify related compounds.


These approaches demonstrate why appropriate analytical reference materials are valuable when investigating pharmaceutical impurities.


Differentiating Clindamycin Sulfoxide, Sulfone, and Phosphate Sulfoxide


One important consideration during impurity analysis is the differentiation of structurally related Clindamycin compounds.


Although their names are similar, these compounds have different molecular compositions and structural characteristics.


Compound

CAS Number

Molecular Formula

Molecular Weight

Clindamycin Sulfoxide

22431-46-5

C18H33ClN2O6S

440.98

Clindamycin Sulfone

887402-22-4

C18H33ClN2O7S

456.98

Clindamycin 2-Phosphate Sulfoxide

1228573-90-7

C18H34ClN2O9PS

520.96

Clindamycin 2-Phosphate Sulfone

Not listed

C18H34ClN2O10PS

536.96


The main structural differences are:

Clindamycin Sulfoxide: Contains the sulfoxide functionality but does not contain the phosphate ester group.


Clindamycin Sulfone: Contains a higher oxidation state of sulfur than the corresponding sulfoxide.


Clindamycin 2-Phosphate Sulfoxide: Contains both the phosphate ester group and the sulfoxide functionality.


Clindamycin 2-Phosphate Sulfone: Contains the phosphate ester group and a sulfone functionality.


Another important consideration is the existence of Clindamycin 2-Phosphate Sulfoxide-related isomers. Chemicea's catalogue separately lists Clindamycin 2-Phosphate Sulfoxide Isomer A and Isomer B. These compounds have the same molecular formula and molecular weight as the principal sulfoxide listing but different CAS numbers.

Therefore, analysts should carefully consider stereochemical identity and reference-standard selection when investigating these compounds.


Role of Reference Standards in Analytical Research


Reference standards play an important role in pharmaceutical analytical development. They provide characterized materials that researchers can use to support the identification and evaluation of specific chemical compounds.


For Clindamycin 2-Phosphate Sulfoxide, an appropriate reference standard can be useful during method development and impurity profiling.


Its potential applications include:


1. Analytical Method Development


Researchers can use an appropriate reference material to investigate chromatographic behaviour and optimize separation from the parent compound and other related impurities.


2. Impurity Identification


Reference materials provide a basis for comparing analytical responses, including retention behaviour and mass spectrometric characteristics.


3. Method Specificity Studies


The presence of structurally related compounds can create analytical challenges. Suitable impurity standards help researchers evaluate whether a method can distinguish the compounds relevant to its intended application.


4. Pharmaceutical Quality Control


Characterized reference materials can support investigations into the related-substance profile of pharmaceutical ingredients and formulations.


5. Research and Development


Reference standards are useful in pharmaceutical research involving degradation studies, impurity investigations, and analytical characterization.


The selection of a reference standard should consider its identity, characterization documentation, purity information, and suitability for the intended analytical application.

Chemicea's Clindamycin 2-Phosphate Sulfoxide Reference Standard

Chemicea Pharmaceuticals Pvt. Ltd. is a chemistry-driven pharmaceutical company and contract research organization specializing in pharmaceutical impurity reference standards, custom synthesis, and analytical research solutions.


Its product portfolio includes pharmaceutical impurities, process-related compounds, degradation products, nitrosamine impurities, and other specialized reference materials.


Chemicea offers Clindamycin 2-Phosphate Sulfoxide under the following product details:


Clindamycin 2-Phosphate Sulfoxide


Product specification

Details

CAS Number

1228573-90-7

Molecular Formula

C18H34ClN2O9PS

Molecular Weight

520.96 g/mol

Product Category

Pharmaceutical Impurity Standard

Availability

Custom Synthesis


Chemicea's capabilities in pharmaceutical impurity synthesis and reference-standard development support researchers requiring specialized chemical materials for analytical investigations.


Its broader Clindamycin impurity portfolio also includes Clindamycin Phosphate-related impurities, Clindamycin Sulfoxide, Clindamycin Sulfone, Clindamycin 2-Phosphate Sulfone, and separately listed sulfoxide isomers.


For pharmaceutical organizations and analytical laboratories, access to such related compounds can help support more comprehensive impurity investigations.


Chemicea also provides custom synthesis capabilities for specialized pharmaceutical impurities and reference materials where specific compounds are required for research and development.


Frequently Asked Questions (FAQs)


1. What is Clindamycin 2-Phosphate Sulfoxide?

Clindamycin 2-Phosphate Sulfoxide is a sulfur-oxidized derivative of Clindamycin Phosphate. Its structure contains both a sulfoxide functional group and a phosphate ester group. It is relevant to pharmaceutical impurity identification and analytical research.


2. What is the CAS number of Clindamycin 2-Phosphate Sulfoxide?

The CAS Registry Number is 1228573-90-7.


3. What is the molecular formula of Clindamycin 2-Phosphate Sulfoxide?

Its molecular formula is C18H34ClN2O9PS, with a molecular weight of approximately 520.96 g/mol.


4. How does Clindamycin 2-Phosphate Sulfoxide differ from Clindamycin Sulfoxide?

Clindamycin 2-Phosphate Sulfoxide contains an additional phosphate ester group in its molecular structure. Clindamycin Sulfoxide does not contain this phosphate group. Their molecular formulas and molecular weights are therefore different.


5. Which analytical techniques are useful for characterizing Clindamycin 2-Phosphate Sulfoxide?

HPLC, LC-MS, HRMS, NMR, and FTIR can provide complementary information for its characterization. The appropriate combination depends on the analytical objective and the degree of structural confirmation required.


6. Why are impurity reference standards important for Clindamycin Phosphate analysis?

Impurity reference standards help analytical researchers identify and evaluate related compounds, investigate chromatographic separation, and assess the specificity of analytical methods.


7. Does Chemicea offer Clindamycin 2-Phosphate Sulfoxide?

Yes. Chemicea lists Clindamycin 2-Phosphate Sulfoxide under catalogue number CP-C26015, CAS number 1228573-90-7, with custom synthesis availability.


Clindamycin 2-Phosphate Sulfoxide is an important structurally related compound for pharmaceutical impurity research involving Clindamycin Phosphate. Its molecular structure contains both a phosphate ester group and an oxidized sulfur functionality, making its identification and differentiation from other Clindamycin-related compounds particularly relevant to analytical investigations.


Understanding its chemical characteristics and applying suitable analytical techniques, including HPLC, LC-MS, HRMS, and NMR, can help researchers investigate related substances and improve impurity profiling strategies.


The availability of appropriately characterized impurity reference standards is valuable for pharmaceutical analytical development, quality-control investigations, and research applications.


Chemicea Pharmaceuticals supports these requirements through its pharmaceutical impurity reference-standard portfolio, custom synthesis capabilities, and chemistry-focused research solutions. Its Clindamycin 2-Phosphate Sulfoxide offering provides an additional resource for laboratories and pharmaceutical researchers working with Clindamycin-related impurities.



 
 
 

Comments


© 2035 by My Weight Lost Journey. Powered and secured by Wix

bottom of page